Quantitative analysis of castration resistant prostate cancer progression through phosphoproteome signaling.Kaplan, David, 1953-
Lescarbeau, Reynald M.
Although recent progress has been made in treating castration resistant prostate cancer, the interplay of signaling pathways which enable castration resistant growth is incompletely understood. A data driven, multivariate approach, was used in this study to predict prostate cancer cell survival based on the phosphorylation levels of key proteins in PC3, LNCaP, and MDA-PCa-2b cell lines in response... read more
- Tufts University. Department of Biomedical Engineering.
- Permanent URL
- Original publication
- Lescarbeau, R. M. and D. L. Kaplan (2014). "Quantitative analysis of castration resistant prostate cancer progression through phosphoproteome signaling." BMC Cancer 14(1). doi: 10.1186/1471-2407-14-325.